Thorhildur Halldorsdottir1, Charlotte Piechaczek1, Ana Paula Soares de Matos1, Darina Czamara1, Verena Pehl1, Petra Wagenbuechler1, Lisa Feldmann1, Peggy Quickenstedt-Reinhardt1, Antje-Kathrin Allgaier1, Franz Joseph Freisleder1, Ellen Greimel1, Tuomas Kvist1, Jari Lahti1, Katri Räikkönen1, Monika Rex-Haffner1, Eiríkur Örn Arnarson1, W Edward Craighead1, Gerd Schulte-Körne1, Elisabeth B Binder1. 1. Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich (Halldorsdottir, Czamara, Rex-Haffner, Binder); Center of Public Health Sciences (Halldorsdottir) and Landspitali National University Hospital, School of Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik (Arnarson); Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, University Hospital, Ludwig Maximilian University, Munich (Piechaczek, Pehl, Wagenbuechler, Feldmann, Quickenstedt-Reinhardt, Allgaier, Greimel, Schulte-Körne); Faculty of Psychology and Educational Sciences, University of Coimbra, Coimbra, Portugal (Soares de Matos); Department of Psychology, Faculty of Social Sciences, University of the German Federal Armed Forces, Neubiberg, Germany (Allgaier); KBO Heckscher Hospital, Munich (Freisleder); Department of Psychology and Logopedics, University of Helsinki, Helsinki (Kvist, Lahti, Räikkönen); Department of Psychiatry and Behavioral Sciences (Craighead, Binder) and Department of Psychology (Craighead), Emory University School of Medicine, Atlanta; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium (see online supplement for list of researchers).
Abstract
OBJECTIVE: Identifying risk factors for major depression and depressive symptoms in youths could have important implications for prevention efforts. This study examined the association of polygenic risk scores (PRSs) for a broad depression phenotype derived from a large-scale genome-wide association study (GWAS) in adults, and its interaction with childhood abuse, with clinically relevant depression outcomes in clinical and epidemiological youth cohorts. METHODS: The clinical cohort comprised 279 youths with major depression (mean age=14.76 years [SD=2.00], 68% female) and 187 healthy control subjects (mean age=14.67 years [SD=2.45], 63% female). The first epidemiological cohort included 1,450 youths (mean age=13.99 years [SD=0.92], 63% female). Of those, 694 who were not clinically depressed at baseline underwent follow-ups at 6, 12, and 24 months. The replication epidemiological cohort comprised children assessed at ages 8 (N=184; 49.2% female) and 11 (N=317; 46.7% female) years. All cohorts were genome-wide genotyped and completed measures for major depression, depressive symptoms, and/or childhood abuse. Summary statistics from the largest GWAS to date on depression were used to calculate the depression PRS. RESULTS: In the clinical cohort, the depression PRS predicted case-control status (odds ratio=1.560, 95% CI=1.230-1.980), depression severity (β=0.177, SE=0.069), and age at onset (β=-0.375, SE=0.160). In the first epidemiological cohort, the depression PRS predicted baseline depressive symptoms (β=0.557, SE=0.200) and prospectively predicted onset of moderate to severe depressive symptoms (hazard ratio=1.202, 95% CI=1.045-1.383). The associations with depressive symptoms were replicated in the second epidemiological cohort. Evidence was found for an additive, but not an interactive, effect of the depression PRS and childhood abuse on depression outcomes. CONCLUSIONS: Depression PRSs derived from adults generalize to depression outcomes in youths and may serve as an early indicator of clinically significant levels of depression.
OBJECTIVE: Identifying risk factors for major depression and depressive symptoms in youths could have important implications for prevention efforts. This study examined the association of polygenic risk scores (PRSs) for a broad depression phenotype derived from a large-scale genome-wide association study (GWAS) in adults, and its interaction with childhood abuse, with clinically relevant depression outcomes in clinical and epidemiological youth cohorts. METHODS: The clinical cohort comprised 279 youths with major depression (mean age=14.76 years [SD=2.00], 68% female) and 187 healthy control subjects (mean age=14.67 years [SD=2.45], 63% female). The first epidemiological cohort included 1,450 youths (mean age=13.99 years [SD=0.92], 63% female). Of those, 694 who were not clinically depressed at baseline underwent follow-ups at 6, 12, and 24 months. The replication epidemiological cohort comprised children assessed at ages 8 (N=184; 49.2% female) and 11 (N=317; 46.7% female) years. All cohorts were genome-wide genotyped and completed measures for major depression, depressive symptoms, and/or childhood abuse. Summary statistics from the largest GWAS to date on depression were used to calculate the depression PRS. RESULTS: In the clinical cohort, the depression PRS predicted case-control status (odds ratio=1.560, 95% CI=1.230-1.980), depression severity (β=0.177, SE=0.069), and age at onset (β=-0.375, SE=0.160). In the first epidemiological cohort, the depression PRS predicted baseline depressive symptoms (β=0.557, SE=0.200) and prospectively predicted onset of moderate to severe depressive symptoms (hazard ratio=1.202, 95% CI=1.045-1.383). The associations with depressive symptoms were replicated in the second epidemiological cohort. Evidence was found for an additive, but not an interactive, effect of the depression PRS and childhood abuse on depression outcomes. CONCLUSIONS:Depression PRSs derived from adults generalize to depression outcomes in youths and may serve as an early indicator of clinically significant levels of depression.
Authors: Liliana Garcia-Mondragon; Deniz Konac; Joanne B Newbury; Katherine S Young; Alex Ing; Anna E Fürtjes; Edward D Barker Journal: Transl Psychiatry Date: 2022-06-22 Impact factor: 7.989
Authors: José A López-López; Alex S F Kwong; Liz Washbrook; Kate Tilling; Mina S Fazel; Rebecca M Pearson Journal: J Affect Disord Date: 2021-02-05 Impact factor: 4.839
Authors: Till F M Andlauer; Nazanin Mirza-Schreiber; Kristina Moll; Johannes Schumacher; Markus M Nöthen; Bertram Müller-Myhsok; Gerd Schulte-Körne; Alessandro Gialluisi; Jessica Becker; Per Hoffmann; Kerstin U Ludwig; Darina Czamara; Beate St Pourcain; Ferenc Honbolygó; Dénes Tóth; Valéria Csépe; Guillaume Huguet; Yves Chaix; Stephanie Iannuzzi; Jean-Francois Demonet; Andrew P Morris; Jacqueline Hulslander; Erik G Willcutt; John C DeFries; Richard K Olson; Shelley D Smith; Bruce F Pennington; Anniek Vaessen; Urs Maurer; Heikki Lyytinen; Myriam Peyrard-Janvid; Paavo H T Leppänen; Daniel Brandeis; Milene Bonte; John F Stein; Joel B Talcott; Fabien Fauchereau; Arndt Wilcke; Holger Kirsten; Bent Müller; Clyde Francks; Thomas Bourgeron; Anthony P Monaco; Franck Ramus; Karin Landerl; Juha Kere; Thomas S Scerri; Silvia Paracchini; Simon E Fisher Journal: Mol Psychiatry Date: 2020-10-14 Impact factor: 13.437
Authors: Sivan Kinreich; Vivia V McCutcheon; Fazil Aliev; Jacquelyn L Meyers; Chella Kamarajan; Ashwini K Pandey; David B Chorlian; Jian Zhang; Weipeng Kuang; Gayathri Pandey; Stacey Subbie-Saenz de Viteri; Meredith W Francis; Grace Chan; Jessica L Bourdon; Danielle M Dick; Andrey P Anokhin; Lance Bauer; Victor Hesselbrock; Marc A Schuckit; John I Nurnberger; Tatiana M Foroud; Jessica E Salvatore; Kathleen K Bucholz; Bernice Porjesz Journal: Transl Psychiatry Date: 2021-03-15 Impact factor: 6.222